Kemira sets forth to amplify its sodium borohydride powder production capacity in Finland

Kemira has decided to expand the sodium borohydride powder production capacity at its Äetsä facility in Finland. The investment involves constructing a new production line and implementing additional process safety upgrades, with the total project value remaining below ten million euros. This expansion aims to support the growing global pharmaceutical industry, particularly in mainland Europe and export markets, by increasing the supply of this critical reducing agent.

Sodium borohydride serves as an essential component in numerous pharmaceutical manufacturing processes and active pharmaceutical ingredient technologies, in addition to its applications across various chemical production processes.

Read More About Sodium Borohydride Production Cost Reports - Get Free Sample Copy in PDF

The company has observed rising demand from pharmaceutical customers in both India and Europe. By more than doubling the plant's drying capacity, Kemira will enhance its ability to meet customer requirements while reinforcing its European manufacturing base. Currently in the engineering phase, the new production line is scheduled to become fully operational by the fourth quarter of 2026. This strategic investment underscores Kemira's commitment to supporting the pharmaceutical sector's evolving needs through expanded production capabilities and improved operational efficiency.